Zentek (ZTEKF) stock price is $0.39, down 9.30% on the day, as of Oct 15, 2026. It has a market cap of $42.04Mn and a P/E ratio of 10.85, and is classified in the Specialty Chemicals industry (Basic Materials sector).
Enterprise Value
Margins
P/FCF
Key Stats
Market Cap42.04 Mn
P/E10.85
Add ratio to table…
About
Zentek Ltd. is a research and development company that focuses on graphene nanomaterials and their application in advanced materials clean technology and green energy solutions. The company leverages its intellectual property laboratory capabilities and university partnerships to develop products such as antimicrobial coatings and functionalized graphene additives.
Zentek Ltd. generates revenue primarily through the sale of its ZenGUARD antimicrobial coating to partners who…
Zentek Ltd. is a research and development company that focuses on graphene nanomaterials and their application in advanced materials clean technology and green energy solutions. The company leverages its intellectual property laboratory capabilities and university partnerships to develop products such as antimicrobial coatings and functionalized graphene additives.
Zentek Ltd. generates revenue primarily through the sale of its ZenGUARD antimicrobial coating to partners who incorporate it into personal protective equipment and HVAC filters. Additional revenue comes from licensing agreements for its patented technologies and from the sale of coated materials to distributors such as EkoMed VMedCare and Southmedic.
Zentek Ltd. occupies a niche within the broader graphene industry where it differentiates itself through a portfolio of patented antimicrobial technologies and a potential vertical integration route via its wholly owned Albany Graphite Project. The company competes with other graphene producers and advanced material firms but believes its scientific know how intellectual property and pilot scale production capabilities give it a competitive edge.
Zentek Ltd. sells its coated products to personal protective equipment manufacturers HVAC system suppliers and distributors including EkoMed VMedCare and Southmedic. The company also works with other parties interested in representing or distributing its products in markets such as Europe India Australia and Asia.
Sector:Basic MaterialsSector rationaleZentek's core business is the development and sale of graphene nanomaterials and functionalized graphene additives, which are intermediate materials sold to other manufacturers. The company also owns the Albany Graphite Project, further aligning it with the extraction and processing of raw materials. A secondary sector of Industrials is included because the company sells antimicrobial coatings specifically for HVAC filters and PPE, and operates pilot-scale production for these industrial applications.Industries:Specialty ChemicalsSpecialty ChemicalsPrimaryZentek develops and sells functionalized graphene additives and advanced nanomaterials, which are performance-based specialty chemicals. These products are formulated for specific applications in clean technology and green energy solutions.Paints and CoatingsPaints and CoatingsSecondaryThe company generates primary revenue from the sale of ZenGUARD, an antimicrobial coating sold to partners for use in personal protective equipment and HVAC filters.Industrial MineralsIndustrial MineralsSecondaryZentek owns the Albany Graphite Project, indicating a business line involved in the extraction and processing of graphite, a non-metallic industrial mineral.Classified using BQ-MICSCIK: 0001904501